EUVIMEDEUVIMED entdecken
Multizentrische Studie

Optimal Oversizing in Transcatheter Aortic Valve Replacement with the Self-Expanding Evolut Valve System

Silvia Mas-Peiro, Alberto Alperi, Marisa Avvedimento, Ander Regueiro, Pablo Avanzas, Domenico Angellotti, Giovanni Esposito, Pablo Vidal-Cales, Siamak Mohammadi, Julio Farjat-Pasos, Cesar Moris, Josep Rodés-Cabau

Journal of Invasive Cardiology · 2024

DOI: 10.25270/jic/24.00011 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Invasive Cardiology, 2024. Verfasst von Silvia Mas-Peiro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Multidetector Computed Tomography, Aortic Valve. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Valve oversizing has been associated with reduced paravalvular leaks (PVL) and valve migration risk. However, no optimal cut-off oversizing value has been defined for the Evolut system (Medtronic). The aim of this study was to assess the relationship between the degree of oversizing and moderate-to-severe PVL and determine the optimal oversizing cut-off value. METHODS: We conducted a multicenter study that included 740 consecutive patients with multidetector computed tomography (CT) data. Valve size was selected according to manufacturer recommendations, with oversizing ranging from 10% to 30%. The primary endpoint was moderate-to-severe PVL. RESULTS: The median age was 84 years (79-87 years), with 58.4% women, and a median EuroSCORE II of 4.1% (2.4-7.3%). Moderate-to-severe PVL was observed in 7.0% of the patients. An inverse relationship was found between oversizing and both PVL (11.3%, 8.6%, 5.4%, and 2.7% for quartiles Q1 to Q4; P = .007) and the need for post-dilation (P = .016). The multivariable analysis showed an association between oversizing and PVL (OR: 0.915 for each 1%-increase, P = .002). The optimal oversizing cut-off value to predict PVL was 20%, and PVL was significantly higher in patients with oversizing less than 20% (10.5% vs.4.2%, P less than .001). There were no differences in major clinical events according to the degree of oversizing, and a higher oversizing did not translate into an increased risk of permanent pacemaker (18.4% vs18.3%, P = .976). CONCLUSIONS: In TAVR with the Evolut valve, a higher oversizing was associated with lower rates of moderate-to-severe PVL and a lower need for post-dilation, with no negative impact on procedural and early clinical outcomes. A 20% oversizing threshold could be suggested to reduce PVLs. Further prospective studies are warranted to validate optimal oversizing for this valve system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisMultidetector Computed TomographyAortic ValveProsthesis DesignHeart Valve ProsthesisHumansFemaleMaleAged, 80 and overAgedRetrospective StudiesTreatment OutcomeFollow-Up StudiesPostoperative Complications

Stichwörter der Autor:innen

TAVRaortic valve stenosisoversizingparavalvular leakself-expandabletranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Cardiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
  • Cardiology Department, Instituto Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; Cardiology Department, Instituto Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain and Institut d'Investigacions Biomèdiques August…

Zitieren

APA

Mas-Peiro, S., Alperi, A., Avvedimento, M., Regueiro, A., Avanzas, P., Angellotti, D., Esposito, G., Vidal-Cales, P., Mohammadi, S., Farjat-Pasos, J., Moris, C., & Rodés-Cabau, J. (2024). Optimal Oversizing in Transcatheter Aortic Valve Replacement with the Self-Expanding Evolut Valve System. Journal of Invasive Cardiology. https://doi.org/10.25270/jic/24.00011

Vancouver

Mas-Peiro S, Alperi A, Avvedimento M, Regueiro A, Avanzas P, Angellotti D, et al. Optimal Oversizing in Transcatheter Aortic Valve Replacement with the Self-Expanding Evolut Valve System. Journal of Invasive Cardiology. 2024. doi:10.25270/jic/24.00011

BibTeX
@article{MasPeiro2024,
  author = {Mas-Peiro, Silvia and Alperi, Alberto and Avvedimento, Marisa and Regueiro, Ander and Avanzas, Pablo and Angellotti, Domenico and Esposito, Giovanni and Vidal-Cales, Pablo and Mohammadi, Siamak and Farjat-Pasos, Julio and Moris, Cesar and Rodés-Cabau, Josep},
  title = {Optimal Oversizing in Transcatheter Aortic Valve Replacement with the Self-Expanding Evolut Valve System},
  journal = {Journal of Invasive Cardiology},
  year = {2024},
  doi = {10.25270/jic/24.00011}
}
Kostenlos starten →